BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1392162)

  • 1. [Multiple myeloma: current therapeutic approaches].
    Troussard X; Bauduer F; Leporrier M
    Bull Cancer; 1992; 79(3):231-42. PubMed ID: 1392162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current and future approaches to therapy for multiple myeloma].
    Nara N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and therapy of multiple myeloma: current aspects].
    Betticher DC; Cerny T; Fey MF
    Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of multiple myeloma].
    Ludwig H; Kührer I
    Wien Klin Wochenschr; 1994; 106(14):448-54. PubMed ID: 7941591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progress in the treatment of multiple myeloma].
    Wada M; Mizoguchi H
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of refractory multiple myeloma. II. Therapy using high doses of alkylating cytostatic agents and radiotherapy in addition to interferon and bone marrow transplantation].
    Adam Z
    Vnitr Lek; 1993 Apr; 39(4):385-400. PubMed ID: 8351869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent biological and therapeutic advances in multiple myeloma].
    Coppetelli U; Avvisati G; Tribalto M; Cantonetti M; La Verde G; Petrucci T; Stasi R; Papa G
    Recenti Prog Med; 1992 Sep; 83(9):520-7. PubMed ID: 1439122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of multiple myeloma].
    La Verde G; Pulsoni A; Petrucci MT; Mandelli F
    Recenti Prog Med; 1997 Apr; 88(4):186-93. PubMed ID: 9206817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of multiple myeloma.
    Richards JD; Singer CR; Tobias JS
    Br J Hosp Med; 1987 May; 37(5):437, 440-2. PubMed ID: 2437986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon therapy in multiple myeloma].
    Micksche M
    Wien Med Wochenschr; 1993; 143(16-17):425-8. PubMed ID: 8273366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of multiple myeloma.
    Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
    Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of multiple myeloma by high dose chemotherapy, total body irradiation and autologous blood stem cell autograft.
    Fermand JP; Lévy Y; Gerota J; Benbunan M; Cosset JM; Castaigne S; Seligmann M; Brouet JC
    Nouv Rev Fr Hematol (1978); 1989; 31(2):85-7. PubMed ID: 2570400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple myeloma: the therapeutic options].
    Sánchez Fayos J; Prieto E; Roman A; Olavarria E
    An Med Interna; 1992 Feb; 9 Spec No():112-8. PubMed ID: 1550902
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
    Reece DE; Brockington DA; Phillips GL; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Shepherd JD
    Bone Marrow Transplant; 2000 Sep; 26(6):621-6. PubMed ID: 11041567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment.
    Powles R; Raje N; Milan S; Millar B; Shepherd V; Mehta J; Singhal S; Kulkarni S; Viner C; Gore M; Cunningham D; Treleaven J
    Bone Marrow Transplant; 1997 Sep; 20(6):435-43. PubMed ID: 9313875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is alpha-interferon treatment in multiple myeloma worthwhile?
    Avvisati G; Petrucci MT
    Stem Cells; 1995 Aug; 13 Suppl 2():106-13. PubMed ID: 8520497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy.
    Attal M; Huguet F; Schlaifer D; Payen C; Lassoued S; Laroche M; Rossi JF; Fournie B; Mazieres B; Pris J
    Bone Marrow Transplant; 1991 Aug; 8(2):125-8. PubMed ID: 1933053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in treatment of multiple myeloma].
    Gola A
    Acta Haematol Pol; 1992; 23(4):229-35. PubMed ID: 1293903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of multiple myeloma--present status and perspectives].
    Robak T
    Acta Haematol Pol; 1996; 27(1):5-14. PubMed ID: 8629444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.